Dexamethasone suppression test reversal in rapid transcranial magnetic stimulation-treated depression

Australian and New Zealand Journal of Psychiatry

Volumn 33, Issue 2, 1999, Pages 274-277

  Reid, Philip D ^a   Pridmore, Saxby ^a  

^a ROYAL HOBART HOSPITAL   (Australia)

Author keywords

Depression; Dexamethasone suppression test; Prolactinoma; Transcranial magnetic stimulation

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BROMOCRIPTINE; DEXAMETHASONE; FLUOXETINE; HYDROCORTISONE; MOCLOBEMIDE; PHENELZINE; PROLACTIN; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MOOD; PROLACTIN BLOOD LEVEL; PROLACTINOMA; RATING SCALE; REMISSION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

ADULT; DEPRESSIVE DISORDER; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; PITUITARY FUNCTION TESTS; PITUITARY NEOPLASMS; PROLACTINOMA; PSYCHOMOTOR DISORDERS; REMISSION INDUCTION; SKULL; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0032905189     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.1999.00550.x     Document Type: Article

References (15)

1. Pascual-Leone A, Rubio B, Pallardo Catala D. Beneficial effect of rapid rate transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in drug resistant depression. Lancet 1996; 384:233-238.
2. Kirkcaldie M, Pridmore S, Pascual-Leone A. Transcranial magnetic stimulation as therapy for depression and other disorders. Australian and New Zealand Journal of Psychiatry 1997; 31:264-272.
3. Pascual-Leone A, Wassermann EM. Repetitive transcranial magnetic stimulation: application and safety considerations. Advances in occupational medicine and rehabilitation. Pavia, Italy: Fondazione Salvatore Maugeri Edizioni, 1996.
4. Carroll BJ, Feinberg M, Greden JF et al. A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Archives of General Psychiatry 1981; 38:15-22.
5. Parker G, Hasdi-Pavlovic D. Melancholia: a disorder of movement and mood. New York: Cambridge University Press, 1996.
6. Montgomery S, Asberg M. A new depression scale designed to be sensitive to change. British Medical Journal 1979; 134:1165-1171.
7. Zung W. A self rating depressive scale. Archives of General Psychiatry 1965; 12:63-70.
8. Pridmore S, Filho JAF, Nahas Z, Liberates C, George MS. Motor threshold in transcranial magnetic stimulation: a comparison of a neurophysiological method and a visualization of movement method. Journal of Electro-Convulsive Therapy 1988; 14:25-27.
9. Sachar EJ, Frantz AG, Altman N, Sassin J. Growth hormone and prolactin in unipolar and bipolar depressed patients: responses to hypoglycaemia and L-dopa. American Journal of Psychiatry 1973; 130:1362-1367.
10. Thienhaus OJ, Hartford JT. Depression in hyperprolactinaemia. Psychosomatics 1986; 27:663-664.
11. Holroyd S, Cohen MJ. Treatment of hyperprolactinaemia in major depression. American Journal of Psychiatry 1990; 147:810.
12. Turner TH, Cookson JC, Wass JAH, Drury PL, Price PA, Besser GM. Psychotic reactions during treatment of pituitary tumours with dopamine agonists. British Medical Journal 1984; 289:1101-1103.
13. The American Psychiatric Association Task Force on Laboratory Tests in Psychiatry. The dexamethasone suppression test: an overview of its current status in psychiatry. American Journal of Psychiatry 1987; 144:1253-1262.
14. Grunhaus L, Dannon P, Schreiber S. Effects of transcranial magnetic stimulation on severe depression. Similarities with ECT. Biological Psychiatry 1998; 43:76S.
15. Meltzer HY, Fang VS. Cortisol determination and the dexamethasone supression test. Archives of General Psychiatry 1983; 40:501-505.